IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 12 holdings | $3.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$2.3M724,20571.0%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$844.0K124,09625.7%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$37.4K2,359,7671.1%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$27.4K3,856,9850.8%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$21.8K807,2240.7%
Ampio Pharmaceuticals Inc.COM03209T109$10.6K2,595,4840.3%
Vascular Biogenics LTDCOMM96883109$6.4K896,7710.2%
Krystal Biotech Inc(KRYS)COM501147102$3.2K300,0000.1%
Soligenix Inc.COM834223307$1.8K870,0000.1%
Volition RX LTD(VNRX)COM928661107$1.0K351,5380.0%
Evoke Pharma IncCOM30049G104$622275,0000.0%
Advaxis Inc.W EXP 07/15/201007624117$113112,5000.0%